16
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Effects of deep brain stimulation amplitude on motor performance in Parkinson’s disease

, , , &
Pages 73-83 | Published online: 11 Dec 2012

References

  • Limousin P, Krack P, Pollak P, et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med. 1998;339:1105–1111.
  • Krack P, Benazzouz A, Pollak P, et al. Treatment of tremor in Parkinson’s disease by subthalamic nucleus stimulation. Mov Disord. 1998;13:907–914.
  • Obeso JA, Guridi J, Rodriguez-Oroz MC, et al. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson’s disease. N Engl J Med. 2001;345:956–963.
  • Bakker M, Esselink RA, Munneke M, Limousin-Dowsey P, Speelman HD, Bloem BR. Effects of stereotactic neurosurgery on postural instability and gait in Parkinson’s disease. Mov Disord. 2004;19: 1092–1099.
  • Dafotakis M, Fink GR, Allert N, Nowak DA. The impact of subthalamic deep brain stimulation on bradykinesia of proximal and distal upper limb muscles in Parkinson’s disease. J Neurol. 2008;255:429–437.
  • Diamond A, Shahed J, Jankovic J. The effects of subthalamic nucleus deep brain stimulation on parkinsonian tremor. J Neurol Sci. 2007;260: 199–203.
  • Plaha P, Ben-Shlomo Y, Patel NK, Gill SS. Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism. Brain. 2006;129:1732–1747.
  • Robertson LT, Horak FB, Anderson VC, Burchiel KJ, Hammerstad JP Assessments of axial motor control during deep brain stimulation in parkinsonian patients. Neurosurgery. 2001;48:544–551.
  • Timmermann L, Braun M, Groiss S, et al. Differential effects of levodopa and subthalamic nucleus deep brain stimulation on bradyki- nesia in Parkinson’s disease. Mov Disord. 2008;23:218–227.
  • Tripoliti E, Zrinzo L, Martinez-Torres I, et al. Effects of contact location and voltage amplitude on speech and movement in bilateral subthalamic nucleus deep brain stimulation. Mov Disord. 2008;23:2377–2383.
  • Kuncel AM, Cooper SE, Wolgamuth BR, et al. Clinical response to varying the stimulus parameters in deep brain stimulation for essential tremor. Mov Disord. 2006;21:1920–1928.
  • Moro E, Esselink RJ, Xie J, Hommel M, Benabid AL, Pollak P. The impact on Parkinson’s disease of electrical parameter settings in STN stimulation. Neurology. 2002;59:706–713.
  • Delwaide PJ, Gonce M. Pathophysiology of Parkinson’s signs. In: Jank-ovic J, Tolosa E, editors. Parkinson’s Disease and Movement Disorders. Philidelphia, PA: Williams and Wilkins; 1998.
  • Guehl D, Cuny E, Benazzouz A, et al. Side-effects of subthalamic stimulation in Parkinson’s disease: clinical evolution and predictive factors. Eur J Neurol. 2006;13:963–971.
  • Vingerhoets FJ, Villemure JG, Temperli P, Pollo C, Pralong E, Ghika J. Subthalamic DBS replaces levodopa in Parkinson’s disease: two-year follow-up. Neurology. 2002;58:396^01.
  • Waldau B, Clayton DA, Gasperson LB, Turner DA. Analysis of the time course of the effect of subthalamic nucleus stimulation upon hand function in Parkinson’s patients. StereotactFunctNeurosurg. 2011;89: 48–55.
  • Schrag A, Sampaio C, Counsell N, Poewe W. Minimal clinically important change on the Unified Parkinson’s Disease Rating Scale. Mov Disord. 2006;21:1200–1207.
  • Hamani C, Richter E, Schwalb JM, Lozano AM. Bilateral subthalamic nucleus stimulation for Parkinson’s disease: a systematic review of the clinical literature. Neurosurgery. 2005;56:1313–1321.
  • Wider C, Pollo C, Bloch J, Burkhard PR, Vingerhoets FJ. Long-term outcome of 50 consecutive Parkinson’s disease patients treated with subthalamic deep brain stimulation. Parkinsonism Relat Disord. 2008; 14:114–119.
  • Bartels AL, Balash Y, Gurevich T, Schaafsma JD, Hausdorff JM, Giladi N. Relationship between freezing of gait (FOG) and other features of Parkinson’s: FOG is not correlated with bradykinesia. J Clin Neurosci. 2003;10:584–588.
  • Visser-Vandewalle V van der Linden C, Temel Y, et al. Long-term effects of bilateral subthalamic nucleus stimulation in advanced Parkinson disease: a four year follow-up study. Parkinsonism Relat Disord. 2005;11:157–165.
  • Krause M, Fogel W, Mayer P, Kloss M, Tronnier V Chronic inhibition of the subthalamic nucleus in Parkinson’s disease. J Neurol Sci. 2004; 219:119–124.
  • Vieregge P, Stolze H, Klein C, Heberlein I. Gait quantitation in Parkinson’s disease - locomotor disability and correlation to clinical rating scales. J Neural Transm. 1997;104:237–248.
  • Visser M, Marinus J, Stiggelbout AM, van Hilten JJ. Responsiveness of impairments and disabilities in Parkinson’s disease. Parkinsonism Relat Disord. 2006;12:314–318.
  • Gomez-Esteban JC, Zarranz JJ, Lezcano E, et al. Influence of motor symptoms upon the quality of life of patients with Parkinson’s disease. Eur Neurol. 2007;57:161–165.
  • Martinez-Martin P, Gil-Nagel A, Gracia LM, Gomez JB, Martinez-Sarries J, Bermejo F. Unified Parkinson’s Disease Rating Scale characteristics and structure. Mov Disord. 1994;9:76–83.
  • Stebbins GT, Goetz CG. Factor structure of the Unified Parkinson’s Disease Rating Scale: Motor Examination section. Mov Disord. 1998; 13:633–636.